Skip to main content

Advertisement

SpringerLink
Log in

Extremity Soft Tissue Sarcoma: Role of Local Control

  • Sarcoma (SH Okuno, Section Editor)
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

For localized extremity soft tissue sarcoma (eSTS), treatment is individualized and each patient needs to be evaluated by a multidisciplinary team at a referral sarcoma center specialized in the care of sarcoma. For a majority of patients, treatment for eSTS involves limb-salvage surgery, with or without the addition of radiation therapy. Surgery should only be performed by surgeons specifically fellowship trained in the resection of eSTS. Surgery alone may be considered for small, low-grade, and superficial tumors as long a wide (≥ 2 cm) margin can be achieved. In cases where a less than wide negative margin can be achieved, radiation therapy should be utilized to facilitate a planned close margin resection to preserve critical structures (such as nerves, blood vessels, and bone) without a significant impact on oncologic outcomes. Soft tissue sarcomas are rare, and as such patients often present following an inadvertent excision. In these situations, we recommend preoperative radiation and wide tumor bed re-excision, as rates of residual tumor can be high in this scenario. While there is large amount of evidence to support the use of radiotherapy to enhance local tumor control, the evidence to support the use of chemotherapy to enhance local tumor control is lacking, and as such cannot be recommended for all patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Gronchi A, Colombo C, Raut CP. Surgical management of localized soft tissue tumors. Cancer. 2014;120(17):2638–48. https://doi.org/10.1002/cncr.28715.

    Article  PubMed  Google Scholar 

  2. Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg. 2014;260(3):416–21; discussion 21-2. https://doi.org/10.1097/SLA.0000000000000869.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Jo VY, Doyle LA. Refinements in sarcoma classification in the current 2013 World Health Organization classification of tumours of soft tissue and bone. Surg Oncol Clin N Am. 2016;25(4):621–43. https://doi.org/10.1016/j.soc.2016.05.001.

    Article  PubMed  Google Scholar 

  4. Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv51–67. https://doi.org/10.1093/annonc/mdy096.

    Article  CAS  PubMed  Google Scholar 

  5. Cates JMM. The AJCC 8th edition staging system for soft tissue sarcoma of the extremities or trunk: a cohort study of the SEER database. J Natl Compr Cancer Netw. 2018;16(2):144–52. https://doi.org/10.6004/jnccn.2017.7042.

    Article  Google Scholar 

  6. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14(5):1679–89. https://doi.org/10.1200/JCO.1996.14.5.1679.

    Article  CAS  PubMed  Google Scholar 

  7. •• Lazarides AL, Kerr DL, Nussbaum DP, Kreulen RT, Somarelli JA, Blazer DG 3rd, et al. Soft tissue sarcoma of the extremities: what is the value of treating at high-volume centers? Clin Orthop Relat Res. 2019;477(4):718–27. https://doi.org/10.1097/01.blo.0000533623.60399.1b. Review of the national cancer database and showed that patients treated at a referal, high-volume cancer cnter were at low risk of death compared with those treated at a low-volume cancer center.

    Article  PubMed  Google Scholar 

  8. Gustafson P, Dreinhofer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand. 1994;65(1):47–50. https://doi.org/10.3109/17453679408993717.

    Article  CAS  PubMed  Google Scholar 

  9. Von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, et al. Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16(5):536–63. https://doi.org/10.6004/jnccn.2018.0025.

    Article  Google Scholar 

  10. Pasquali S, Gronchi A. Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications. Ther Adv Med Oncol. 2017;9(6):415–29. https://doi.org/10.1177/1758834017705588.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113(3):573–81. https://doi.org/10.1002/cncr.23592.

    Article  PubMed  Google Scholar 

  12. Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012;13(10):1045–54. https://doi.org/10.1016/S1470-2045(12)70346-7.

    Article  CAS  PubMed  Google Scholar 

  13. •• Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017;18(6):812–22. https://doi.org/10.1016/S1470-2045(17)30334-0. Prospective randomized study of patients with extremity soft tissue sarcoma showing that patients with histoloigcal tailored chemotherapy had worse survival compared with those receiving standard chemotherapy. Also showed the importance of using a chemotherapy with anthracycline-based chemotherapy.

    Article  CAS  PubMed  Google Scholar 

  14. •• Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, et al. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres. Eur J Cancer. 2018;105:19–27. https://doi.org/10.1016/j.ejca.2018.09.028. Multicenter study showing the addition of chemotherapy leads to a 5% survival benefit in propensity matched analysis. Showed that radiotherapy impoved local control in all cases, however especially in certain hisologies such as myxoid liposarcoma, vascular sarcomas, and myxofibrosarcomas.

    Article  PubMed  Google Scholar 

  15. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997;350(9092):1647–54.

  16. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487–97. https://doi.org/10.1016/s1470-2045(02)00818-5.

    Article  CAS  PubMed  Google Scholar 

  17. Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010;11(6):561–70. https://doi.org/10.1016/S1470-2045(10)70071-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Bhangu A, Broom L, Nepogodiev D, Gourevitch D, Desai A. Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: a systematic review. Eur J Surg Oncol. 2013;39(4):311–9. https://doi.org/10.1016/j.ejso.2012.12.018.

    Article  CAS  PubMed  Google Scholar 

  19. O’Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235–41. https://doi.org/10.1016/s0140-6736(02)09292-9.

    Article  PubMed  Google Scholar 

  20. Davis AM, O’Sullivan B, Bell RS, Turcotte R, Catton CN, Wunder JS, et al. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol. 2002;20(22):4472–7. https://doi.org/10.1200/JCO.2002.03.084.

    Article  CAS  PubMed  Google Scholar 

  21. Davis AM, O’Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75(1):48–53. https://doi.org/10.1016/j.radonc.2004.12.020.

    Article  PubMed  Google Scholar 

  22. Chung PW, Deheshi BM, Ferguson PC, Wunder JS, Griffin AM, Catton CN, et al. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas. Cancer. 2009;115(14):3254–61. https://doi.org/10.1002/cncr.24375.

    Article  PubMed  Google Scholar 

  23. Haas RL, Miah AB, LePechoux C, DeLaney TF, Baldini EH, Alektiar K, et al. Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies. Radiother Oncol. 2016;119(1):14–21. https://doi.org/10.1016/j.radonc.2015.12.002.

    Article  PubMed  Google Scholar 

  24. Al Yami A, Griffin AM, Ferguson PC, Catton CN, Chung PW, Bell RS, et al. Positive surgical margins in soft tissue sarcoma treated with preoperative radiation: is a postoperative boost necessary? Int J Radiat Oncol Biol Phys. 2010;77(4):1191–7. https://doi.org/10.1016/j.ijrobp.2009.06.074.

    Article  PubMed  Google Scholar 

  25. Pan E, Goldberg SI, Chen YL, Giraud C, Hornick JL, Nielsen GP, et al. Role of post-operative radiation boost for soft tissue sarcomas with positive margins following pre-operative radiation and surgery. J Surg Oncol. 2014;110(7):817–22. https://doi.org/10.1002/jso.23741.

    Article  PubMed  Google Scholar 

  26. Alamanda VK, Song Y, Shinohara E, Schwartz HS, Holt GE. Postoperative radiation boost does not improve local recurrence rates in extremity soft tissue sarcomas. J Med Imaging Radiat Oncol. 2014;58(5):633–40. https://doi.org/10.1111/1754-9485.12184.

    Article  PubMed  Google Scholar 

  27. Townley WA, Mah E, O’Neill AC, Wunder JS, Ferguson PC, Zhong T, et al. Reconstruction of sarcoma defects following pre-operative radiation: free tissue transfer is safe and reliable. J Plast Reconstr Aesthet Surg. 2013;66(11):1575–9. https://doi.org/10.1016/j.bjps.2013.06.029.

    Article  CAS  PubMed  Google Scholar 

  28. Bedi M, King DM, DeVries J, Hackbarth DA, Neilson JC. Does vacuum-assisted closure reduce the risk of wound complications in patients with lower extremity sarcomas treated with preoperative radiation? Clin Orthop Relat Res. 2019;477(4):768–74. https://doi.org/10.1097/CORR.0000000000000371.

    Article  PubMed  Google Scholar 

  29. Holt GE, Griffin AM, Pintilie M, Wunder JS, Catton C, O’Sullivan B, et al. Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-tissue sarcomas. A comparison of high-dose and low-dose radiotherapy. J Bone Joint Surg Am. 2005;87(2):315–9. https://doi.org/10.2106/JBJS.C.01714.

    Article  PubMed  Google Scholar 

  30. Dickie CI, Parent AL, Griffin AM, Fung S, Chung PW, Catton CN, et al. Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: relationship to irradiated bone length, volume, tumor location and dose. Int J Radiat Oncol Biol Phys. 2009;75(4):1119–24. https://doi.org/10.1016/j.ijrobp.2008.12.006.

    Article  PubMed  Google Scholar 

  31. Patel SR. Radiation-induced sarcoma. Curr Treat Options in Oncol. 2000;1(3):258–61.

    Article  CAS  Google Scholar 

  32. Gladdy RA, Qin LX, Moraco N, Edgar MA, Antonescu CR, Alektiar KM, et al. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010;28(12):2064–9. https://doi.org/10.1200/JCO.2009.25.1728.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Sheppard DG, Libshitz HI. Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol. 2001;56(1):22–9. https://doi.org/10.1053/crad.2000.0599.

    Article  CAS  PubMed  Google Scholar 

  34. Li XA, Chen X, Zhang Q, Kirsch DG, Petersen I, DeLaney TF, et al. Margin reduction from image guided radiation therapy for soft tissue sarcoma: secondary analysis of Radiation Therapy Oncology Group 0630 results. Pract Radiat Oncol. 2016;6(4):e135–40. https://doi.org/10.1016/j.prro.2015.11.012.

    Article  PubMed  Google Scholar 

  35. O’Sullivan B, Griffin AM, Dickie CI, Sharpe MB, Chung PW, Catton CN, et al. Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma. Cancer. 2013;119(10):1878–84. https://doi.org/10.1002/cncr.27951.

    Article  PubMed  Google Scholar 

  36. Folkert MR, Singer S, Brennan MF, Kuk D, Qin LX, Kobayashi WK, et al. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol. 2014;32(29):3236–41. https://doi.org/10.1200/JCO.2013.53.9452.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Kosela-Paterczyk H, Szumera-Cieckiewicz A, Szacht M, Haas R, Morysinski T, Dziewirski W, et al. Efficacy of neoadjuvant hypofractionated radiotherapy in patients with locally advanced myxoid liposarcoma. Eur J Surg Oncol. 2016;42(6):891–8. https://doi.org/10.1016/j.ejso.2016.02.258.

    Article  CAS  PubMed  Google Scholar 

  38. Yuce Sari S, Cengiz M, Dauletkazin A, Yazici G, Gultekin M, Hurmuz P, et al. Hypofractionated radiotherapy for non-metastatic bone and soft tissue sarcomas. Cancer Radiother. 2019. https://doi.org/10.1016/j.canrad.2019.06.011. Early results of a heterogenous group of patients receiving hypofractionated radiotherapy showing this could be a promising way to treat patients with soft tissues sarcomas and may reduce the risk of complications.

    Article  CAS  Google Scholar 

  39. Roeder F, Lehner B, Saleh-Ebrahimi L, Hensley FW, Ulrich A, Alldinger I, et al. Intraoperative electron radiation therapy combined with external beam radiation therapy and limb sparing surgery in extremity soft tissue sarcoma: a retrospective single center analysis of 183 cases. Radiother Oncol. 2016;119(1):22–9. https://doi.org/10.1016/j.radonc.2015.11.014.

    Article  PubMed  Google Scholar 

  40. • Roeder F, de Paoli A, Saleh-Ebrahimi L, Alldinger I, Bertola G, Boz G, et al. Intraoperative electron radiation therapy combined with external beam radiation therapy after gross total resection in extremity soft tissue sarcoma: a European pooled analysis. Ann Surg Oncol. 2018;25(13):3833–42. https://doi.org/10.1245/s10434-018-6787-9 Review of several studies examining the utility of intraoperative boost of radiotherapy and showed that intraoperative radiotherapy fails to salvage a positive margin in patients with soft tissue sarcoma and the authors recommend a re-excision when possible.

    Article  PubMed  Google Scholar 

  41. Naghavi AO, Fernandez DC, Mesko N, Juloori A, Martinez A, Scott JG, et al. American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy. Brachytherapy. 2017;16(3):466–89. https://doi.org/10.1016/j.brachy.2017.02.004.

    Article  CAS  PubMed  Google Scholar 

  42. Alektiar KM, Hu K, Anderson L, Brennan MF, Harrison LB. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 2000;47(1):157–63. https://doi.org/10.1016/s0360-3016(99)00546-5.

    Article  CAS  PubMed  Google Scholar 

  43. Alekhteyar KM, Leung DH, Brennan MF, Harrison LB. The effect of external beam radiotherapy and brachytherapy on local control and wound complications in patients with high-grade soft tissue sarcomas of the extremity with positive microscopic margin. Int J Radiat Oncol Biol Phys. 1996;36(2):321–4. https://doi.org/10.1016/s0360-3016(96)00331-8.

    Article  CAS  PubMed  Google Scholar 

  44. DeLaney TF, Haas RL. Innovative radiotherapy of sarcoma: proton beam radiation. Eur J Cancer. 2016;62:112–23. https://doi.org/10.1016/j.ejca.2016.04.015.

    Article  PubMed  Google Scholar 

  45. Fogliata A, Scorsetti M, Navarria P, Catalano M, Clivio A, Cozzi L, et al. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy. Acta Oncol. 2013;52(3):545–52. https://doi.org/10.3109/0284186X.2012.689853.

    Article  PubMed  Google Scholar 

  46. Whitley MJ, Cardona DM, Lazarides AL, Spasojevic I, Ferrer JM, Cahill J, et al. A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer. Sci Transl Med. 2016;8(320):320ra4. https://doi.org/10.1126/scitranslmed.aad0293.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. O’Donnell PW, Griffin AM, Eward WC, Sternheim A, Catton CN, Chung PW, et al. The effect of the setting of a positive surgical margin in soft tissue sarcoma. Cancer. 2014;120(18):2866–75. https://doi.org/10.1002/cncr.28793.

    Article  PubMed  Google Scholar 

  48. Clarkson PW, Griffin AM, Catton CN, O’Sullivan B, Ferguson PC, Wunder JS, et al. Epineural dissection is a safe technique that facilitates limb salvage surgery. Clin Orthop Relat Res. 2005;438:92–6. https://doi.org/10.1097/01.blo.0000180057.22712.53.

    Article  PubMed  Google Scholar 

  49. •• Gundle KR, Kafchinski L, Gupta S, Griffin AM, Dickson BC, Chung PW, et al. Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection. J Clin Oncol. 2018;36(7):704–9. https://doi.org/10.1200/JCO.2017 Single center review of a prospective databased showing that planned close negative and planned close but ultimately positive margins around critical structures are safe when performed with the addition of radiotherapy.

    Article  PubMed  Google Scholar 

  50. Dickinson IC, Whitwell DJ, Battistuta D, Thompson B, Strobel N, Duggal A, et al. Surgical margin and its influence on survival in soft tissue sarcoma. ANZ J Surg. 2006;76(3):104–9. https://doi.org/10.1111/j.1445-2197.2006.03615.x.

    Article  PubMed  Google Scholar 

  51. Novais EN, Demiralp B, Alderete J, Larson MC, Rose PS, Sim FH. Do surgical margin and local recurrence influence survival in soft tissue sarcomas? Clin Orthop Relat Res. 2010;468(11):3003–11. https://doi.org/10.1007/s11999-010-1471-9.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Vraa S, Keller J, Nielsen OS, Jurik AG, Jensen OM. Soft-tissue sarcoma of the thigh: surgical margin influences local recurrence but not survival in 152 patients. Acta Orthop Scand. 2001;72(1):72–7. https://doi.org/10.1080/000164701753606734.

    Article  CAS  PubMed  Google Scholar 

  53. Gronchi A, Miceli R, Fiore M, Collini P, Lozza L, Grosso F, et al. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure. Ann Surg Oncol. 2007;14(5):1583–90. https://doi.org/10.1245/s10434-006-9325-0.

    Article  PubMed  Google Scholar 

  54. Heslin MJ, Woodruff J, Brennan MF. Prognostic significance of a positive microscopic margin in high-risk extremity soft tissue sarcoma: implications for management. J Clin Oncol. 1996;14(2):473–8. https://doi.org/10.1200/JCO.1996.14.2.473.

    Article  CAS  PubMed  Google Scholar 

  55. Stojadinovich A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg. 2002;235(3):424–34. https://doi.org/10.1097/00000658-200203000-00015.

    Article  Google Scholar 

  56. Tanabe KK, Pollock RE, Ellis LM, Murphy A, Sherman N, Romsdahl MM. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer. 1994;73(6):1652–9. https://doi.org/10.1002/1097-0142(19940315)73:6<1652::aid-cncr2820730617>3.0.co;2-x.

    Article  CAS  PubMed  Google Scholar 

  57. Bonvalot S, Levy A, Terrier P, Tzanis D, Bellefqih S, Le Cesne A, et al. Primary extremity soft tissue sarcomas: does local control impact survival? Ann Surg Oncol. 2017;24(1):194–201. https://doi.org/10.1245/s10434-016-5462-2.

    Article  PubMed  Google Scholar 

  58. Eccles C, Whitaker J, Nyland J, Roberts C, Carlson J, Zamora R. Skin fiducial markers enable accurate computerized navigation resection of simulated soft tissue tumors: a static cadaveric model pilot study. J Surg Oncol. 2018;118(3):510–7. https://doi.org/10.1002/jso.25155.

    Article  PubMed  Google Scholar 

  59. Mahjoub A, Morales-Restrepo A, Fourman MS, Mandell JB, Feiqi L, Hankins ML, et al. Tumor resection guided by intraoperative indocyanine green dye fluorescence angiography results in negative surgical margins and decreased local recurrence in an orthotopic mouse model of osteosarcoma. Ann Surg Oncol. 2019;26(3):894–8. https://doi.org/10.1245/s10434-018-07114-9.

    Article  PubMed  Google Scholar 

  60. Gustafson P. Soft tissue sarcoma. Acta Orthop Scand. 1994;Suppl 259(65):2–31. https://doi.org/10.3109/17453679409153928.

    Article  Google Scholar 

  61. Salas S, Stoeckle E, Collin F, Bui B, Terrier P, Guillou L, et al. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database. Eur J Cancer. 2009;45(12):2091–102. https://doi.org/10.1016/j.ejca.2009.03.006.

    Article  PubMed  Google Scholar 

  62. Tsukushi S, Nishida Y, Shido Y, Wasa J, Ishiquiro N. Clinicopathological prognostic factors of superficial non-small round cell soft tissue sarcomas. J Surg Oncol. 2012;105(7):668–72. https://doi.org/10.1002/jso.23025.

    Article  PubMed  Google Scholar 

  63. Haglund KE, Raut CP, Nascimento AF, Wang Q, George S, Baldini EH. Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma. Int J Radiat Oncol Biol Phys. 2012;82(1):361–7. https://doi.org/10.1016/j.ijrobp.2010.08.042.

    Article  PubMed  Google Scholar 

  64. Ghazala CG, Agni NR, Ragbir M, Dildey P, Lee D, Rankin KS. Myxofibrosarcoma of the extremity and trunk: a multidisciplinary approach leads to good local rates of LOCAL control. Bone Joint J. 2016;98-B(12):1682–8. https://doi.org/10.1302/0301-620X.98B12.

    Article  CAS  PubMed  Google Scholar 

  65. Kikuta K, Kubota D, Yoshida A, Suzuki Y, Morioka H, Toyama Y, et al. An analysis of factors related to recurrence of myxofibrosarcoma. Jpn J Clin Oncol. 2013;43(11):1093–104. https://doi.org/10.1093/jjco/hyt119.

    Article  PubMed  Google Scholar 

  66. Huang HY, Lal P, Qin J, Brennan MF, Antonescu CR. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol. 2004;35(5):612–21. https://doi.org/10.1016/j.humpath.2004.01.016.

    Article  PubMed  Google Scholar 

  67. Tsagozis P, Bauer HC, Styring E, Trovik CS, Zaikova O, Brosjo O. Prognostic factors and follow-up strategy for superficial soft-tissue sarcomas: analysis of 622 surgically treated patients from the scandinavian sarcoma group register. J Surg Oncol. 2015;111(8):951–6. https://doi.org/10.1002/jso.23927.

    Article  PubMed  Google Scholar 

  68. Austin JL, Temple WJ, Puloski S, Schachar NS, Oddone Paolucci E, Kurien E, et al. Outcomes of surgical treatment alone in patients with superficial soft tissue sarcoma regardless of size or grade. J Surg Oncol. 2016;113(1):108–13. https://doi.org/10.1002/jso.24091.

    Article  PubMed  Google Scholar 

  69. Eward WC, Lazarides AL, Griffin AM, O’Donnell PW, Sternheim A, O’Neill A, et al. Superficial soft-tissue sarcomas rarely require advanced soft-tissue reconstruction following resection. Plast Reconstr Surg Glob Open. 2017;5(11):e1553. https://doi.org/10.1097/GOX.0000000000001553.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Chandrasekar CR, Wafa H, Grimer RJ, Carter SR, Tillman RM, Abudu A. The effect of unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg (Br). 2008;90(2):203–8. https://doi.org/10.1302/0301-620X.90B2.

    Article  CAS  Google Scholar 

  71. Noria S, Davis A, Kandel R, Levesque J, O’Sullivan B, Wunder J, et al. Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J Bone Joint Surg Am. 1996;78(5):650–5. https://doi.org/10.2106/00004623-199605000-00003.

    Article  CAS  PubMed  Google Scholar 

  72. •• Traub F, Griffin AM, Wunder JS, Ferguson PC. Influence of unplanned excisions on the outcomes of patients with stage III extremity soft-tissue sarcoma. Cancer. 2018;124(19):3868–75. https://doi.org/10.1002/cncr.31648. Large study of patients who present with high risk (large, deep, high-grade tumors) which were inadvertently excised. There was a high rate of residual disease, however with multidisciplinary care these cases are able to salvaged without an impact on oncologic outcome.

    Article  PubMed  Google Scholar 

  73. • Decanter G, Stoeckle E, Honore C, Meeus P, Mattei JC, Dubray-Longeras P, et al. Watch and wait approach for re-excision after unplanned yet macroscopically complete excision of extremity and superficial truncal soft tissue sarcoma is safe and does not affect metastatic risk or amputation rate. Ann Surg Oncol. 2019;26(11):3526–34. https://doi.org/10.1245/s10434-019-07494-6. Authors of this retrospective series question the dogma of re-excision in certain cases of extremity soft tissue sarcoma and offer a “wait and see” approach to certain patients who present after and inadvertent excision.

    Article  PubMed  Google Scholar 

  74. Sugiura H, Tsukushi S, Yoshida M, Nishida Y. What is the success of repeat surgical treatment of a local recurrence after initial wide resection of soft tissue sarcomas? Clin Orthop Relat Res. 2018;476(9):1791–800. https://doi.org/10.1007/s11999.0000000000000158.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Montgomery C, Harris J, Siegel E, Suva L, Wilson M, Morell S, et al. Obesity is associated with larger soft-tissue sarcomas, more surgical complications, and more complex wound closures (obesity leads to larger soft-tissue sarcomas). J Surg Oncol. 2018;118(1):184–91. https://doi.org/10.1002/jso.25119.

    Article  PubMed  Google Scholar 

  76. Houdek MT, Griffin AM, Ferguson PC, Wunder JS. Morbid obesity increases the risk of postoperative wound complications, infection, and repeat surgical procedures following upper extremity limb salvage surgery for soft tissue sarcoma. Hand (N Y). 2019;14(1):114–20. https://doi.org/10.1177/1558944718797336.

    Article  Google Scholar 

  77. Houdek MT, Hevesi M, Griffin AM, Wunder JS, Ferguson PC. Morbid obesity is associated with an increased risk of wound complications and infection after lower extremity soft-tissue sarcoma resection. J Am Acad Orthop Surg. 2019;27(21):807–15. https://doi.org/10.5435/JAAOS-D-18-00536.

    Article  PubMed  Google Scholar 

  78. Mattei JC, Brouste V, Terrier P, Bonvalot S, Lecesne A, Stoeckle E, et al. Distal extremities soft tissue sarcomas: are they so different from other limb localizations? J Surg Oncol. 2019;119(4):479–88. https://doi.org/10.1002/jso.25359.

    Article  PubMed  Google Scholar 

  79. Ferguson PC, Deheshi BM, Chung P, Catton CN, O’Sullivan B, Gupta A, et al. Soft tissue sarcoma presenting with metastatic disease: outcome with primary surgical resection. Cancer. 2011;117(2):372–9. https://doi.org/10.1002/cncr.25418.

    Article  PubMed  Google Scholar 

  80. • Wigge S, Heissner K, Steger V, Ladurner R, Traub F, Sipos B, et al. Impact of surgery in patients with metastatic soft tissue sarcoma: a monocentric retrospective analysis. J Surg Oncol. 2018;118(1):167–76. https://doi.org/10.1002/jso.25115.Review of patients with metastatic soft tissue sarcoma and showed that reesction of extra pulmonary metastases can improve progression-free survival in some patients.

    Article  PubMed  PubMed Central  Google Scholar 

  81. • Pradhan A, Grimer RJ, Abudu A, Tillman RM, Carter SR, Jeys L, et al. Epithelioid sarcomas: how important is loco-regional control? Eur J Surg Oncol. 2017;43(9):1746–52. https://doi.org/10.1016/j.ejso.2017.07.002.Multicenter review of patients with epitheloid sarcoma, advocating for aggressive surgery in patients who present with isolated lymph node metastat disease in the absence of pulmonary metastases.

    Article  CAS  PubMed  Google Scholar 

  82. Davis AM, Wright JG, Williams JI, Bombardier C, Griffin A, Bell RS. Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res. 1996;5(5):508–16. https://doi.org/10.1007/bf00540024.

    Article  CAS  PubMed  Google Scholar 

  83. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241–6.

    Google Scholar 

  84. Wilke B, Cooper A, Scarborough M, Gibbs P, Spiguel A. A comparison of limb salvage versus amputation for nonmetastatic sarcomas using patient-reported outcomes measurement information system outcomes. J Am Acad Orthop Surg. 2019;27(8):e381–e9. https://doi.org/10.5435/JAAOS-D-17-00758.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Elyse J. Brinkmann MD & Matthew T. Houdek MD

  2. Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA

    Safia K. Ahmed MD

Authors
  1. Elyse J. Brinkmann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Safia K. Ahmed MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew T. Houdek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew T. Houdek MD.

Ethics declarations

Conflict of Interest

Elyse J. Brinkmann declares that there is no conflict of interest. Safia K. Ahmed declares that there is no conflict of interest. Matthew T. Houdek declares that there is no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Sarcoma

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brinkmann, E.J., Ahmed, S.K. & Houdek, M.T. Extremity Soft Tissue Sarcoma: Role of Local Control. Curr. Treat. Options in Oncol. 21, 13 (2020). https://doi.org/10.1007/s11864-020-0703-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11864-020-0703-9

Keywords

Search

Navigation